Nanosphere

About:

Nanosphere develops a molecular diagnostics platform for genomic and protein testing and analysis.

Website: http://www.nanosphere.us

Twitter/X: nanosphere

Top Investors: Bain Capital, Allen & Company, Nextgen Partners, Takata Corporation, Lurie Investment Fund

Description:

Nanosphere, Inc. is a nanotechnology-based healthcare company, making clinical diagnostic tests that are two to three times as sensitive as those commonly used in hospital labs today and much simpler, taking just hours rather than days or weeks to complete. The company's instruments, which use microfluidics to pull DNA and proteins from a sample, detect genetic variations in blood that make some drugs more effective in some patients than others. The key is an array of gold nanoparticles studded with chemicals that capture characteristic proteins and nucleic acids from clinical samples such as blood.

Total Funding Amount:

$125M

Headquarters Location:

Northbrook, Illinois, United States

Founded Date:

1999-01-01

Founders:

Chad A. Mirkin, Robert Lewis Letsinger

Number of Employees:

51-100

Last Funding Date:

2015-05-29

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai